Massachusetts Healthcare Eyes Share of the $700 Billion Global Cross-border Medical Market Amid $75 Million Funding Round

Cross-Border Medical Service Platform MassHealth Secures RMB 75 Million in Investment

Wang Jianlin Invests 15 Billion in UK International Hospital Group

Cross-border healthcare has become a fiercely contested arena for capital.

The overall market size of the middle class and new affluent is expanding.

Upgrading the Healthcare Industry,

Seeking medical services abroad,

The number of people seeking medical consultations and treatment is on the rise.

The global medical tourism revenue scale will reach in 2017$678.5 billion

Global medical tourism revenue will account for 16% of the world's total tourism revenue,

The growth rate of medical tourism is twice that of the tourism industry,

The Market Size of China's Cross-Border Medical Services Is Set to Surpass$10 billion。

Hotspots in Venture Capital Investment and Industry Overview of Cross-Border Healthcare

This issue of the Star Sharing Salon invites

Dr. Wu Gongxiong, CEO of Massachusetts Medical Services, a Cross-Border Healthcare Platform

Provide a detailed sharing for colleagues.

(The Star Future Beijing Big Health Roadshow Competition will be held after the Star Sharing session.)

13:30-14:00 Attendee Registration

14:00-14:10 Keynote Sharing: Host's Opening Remarks

14:10-14:30 Keynote Sharing: Venture Capital Opportunities Amidst the Differences Between Chinese and American Healthcare Systems by Wu Gongxiong

14:30-16:10 Project Roadshow and Commentary

16:10-16:30 Awards Ceremony and Closing

Fosun Tonghao

VCBeat

How Much of the “700 Billion” Cross-Border Healthcare Market Can You Capture? (Draft)

Topic 1: Differences Between Healthcare in China and the United States

Topic 2: Opportunities and Challenges in Cross-Border Healthcare

Topic 3: Can the cost of cross-border healthcare be reduced?

Topic 4: Can cross-border healthcare develop a single dominant player?

Topic 5:The Roles and Functions of Hospitals, Third-Party Institutions, and Consumers in the Cross-Border Healthcare Market.